Upload
Featured Recent Articles Topics Login Upload

Search Results for 'rna hcv'

rna hcv published presentations and documents on DocSlides.

Taking Steps to Improve the Management
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Boceprevir in Treatment Experienced
Boceprevir in Treatment Experienced
by tatiana-dople
RESPOND-2. Phase . 3. Treatment. . Experienced. ...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Edited by
Edited by
by celsa-spraggs
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
TURQUOISE-I
TURQUOISE-I
by natalia-silvester
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Edited by
Edited by
by luanne-stotts
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
Current strategies for the management of treatment naïve a
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Arthur Y. Kim, MD
Arthur Y. Kim, MD
by stefany-barnette
Assistant Professor of Medicine. Harvard Medical ...
TURQUOISE-I
TURQUOISE-I
by marina-yarberry
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
2014: HIV, HCV, and HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
H. Nina Kim, MD Assistant Professor of Medicine
H. Nina Kim, MD Assistant Professor of Medicine
by giovanna-bartolotta
Division of Infectious Diseases. University of Wa...
HIV and viral hepatitis co-infection
HIV and viral hepatitis co-infection
by cheryl-pisano
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
OBV/PTV/r DSV RBV OBV/PTV/r
OBV/PTV/r DSV RBV OBV/PTV/r
by ellena-manuel
DSV . placebo. Randomisation*. Partial blind. 1...
ALLY-2
ALLY-2
by aaron
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
ALLY-2
ALLY-2
by tawny-fly
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
LDV/SOF 90/400 mg
LDV/SOF 90/400 mg
by aaron
qd. Non-randomised. Open-label. N =. 21. W12. SV...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
Safety and Efficacy of Daclatasvir
Safety and Efficacy of Daclatasvir
by tabitha
. Plus . Sofosbuvir. With or Without Ribavirin . ...
Webinar presented by : ANDES
Webinar presented by : ANDES
by teresa
Prediction. . of . events. . after. ART. initia...
How to optimize treatment of G1 patients?
How to optimize treatment of G1 patients?
by KissesForYou
Prof. G. K. K. Lau 2012. Standard of care (SOC) ...
Practical management of PI therapy
Practical management of PI therapy
by TropicalParadise
in Hepatitis C . Paris . Februari. 2012. Ola . We...
NS5A and polymerase inhibitors
NS5A and polymerase inhibitors
by LoveBug
Mark Sulkowski, MD. Professor of Medicine. Johns H...
A C U T E H E P A T I T I
A C U T E H E P A T I T I
by riley
S. Definition. HEPATITIS. • Inflammation of live...
Hepatitis viruses: An overview
Hepatitis viruses: An overview
by ruby
Dr. Mohit Bhatia. Assistant Professor. Department ...
Best of Digital ILC 2020
Best of Digital ILC 2020
by jordyn
Viral hepatitis. About these slides. These slides ...
SMV 150 mg QD SOF 400 mg QD
SMV 150 mg QD SOF 400 mg QD
by alida-meadow
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
Two parallel arms
Two parallel arms
by test
Open label. ≥ . 18 years, . HCV genotype 1 to ...
Placebo + PR
Placebo + PR
by aaron
W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...
SMV 150 mg
SMV 150 mg
by faustina-dinatale
qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....
NIAID ERADICATE
NIAID ERADICATE
by tatiana-dople
Open-label. W12. ≥ 18 years. Chronic HCV infect...
SIRIUS
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
Edited by
Edited by
by ellena-manuel
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...